Taken together, these results suggest that overexpression of UBE3C-LRP5 fusion, but not LRP5, is sufficient to induce tumorigenesis in vitro and in vivo and promote migration and invasion of head and neck cancer cells in vitro. Here, UBE3C is linked to head and neck cancer.